XARACOLL 300mg Dose Cohort Experienced Less Pain and XARACOLL was Generally Well Tolerated with an Adverse Event Profile Comparable to...
Read More

About Innocoll
Innocoll is a biotherapeutics pharmaceutical company committed to improving the status quo and finding answers to unmet needs

XARACOLL® (bupivacaine HCl) Implant
Our lead product, XARACOLL, was approved by the U.S. Food and Drug Administration in August 2020